Latest News about ABT
Recent news which mentions ABT
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today
January 19, 2024
From Benzinga
Better Growth Stock: Abbott vs. AbbVie
January 16, 2024
From Motley Fool
Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
January 12, 2024
From Benzinga
From Benzinga
From Motley Fool
Beyond The Numbers: 5 Analysts Discuss Abbott Laboratories Stock
January 03, 2024
Tickers
ABT
From Benzinga
Could Abbott Laboratories Stock Help You Become a Millionaire?
January 03, 2024
Tickers
ABT
From Motley Fool
3 Top Dividend Growth Stocks to Buy in 2024
January 02, 2024
From Motley Fool
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
December 28, 2023
From Benzinga
Silver Economy Successes: 3 Stocks Benefitting From an Aging Population
December 27, 2023
From InvestorPlace
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
December 26, 2023
From Benzinga
5 Top Stocks to Buy With Your End-of-the-Year Bonus
December 23, 2023
From Motley Fool
Better Growth Stock: AbbVie vs. Abbott Laboratories
December 21, 2023
From Motley Fool
3 No-Brainer Healthcare Stocks to Buy Right Now
December 15, 2023
From Motley Fool
2 Healthcare Stocks to Buy Hand Over Fist in December
December 08, 2023
From Motley Fool
From Motley Fool
Peering Into Abbott Laboratories's Recent Short Interest
December 01, 2023
Tickers
ABT
From Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
November 30, 2023
Tickers
ABT
From Benzinga
Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality'
November 30, 2023
From Benzinga
Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration
November 21, 2023
From Benzinga
From MarketWatch
From Motley Fool
3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing
November 14, 2023
From Motley Fool
Who’s afraid of Ozempic? From restaurants to package makers, companies work to calm investors’ GLP-1 jitters.
November 10, 2023
From MarketWatch
2 No-Brainer Stocks to Buy for Forever Dividend Growth
November 09, 2023
From Motley Fool
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity
November 08, 2023
From Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.